Aims: Desmoid-type fibromatosis (DF) is a rare benign myofibroblastic neoplasm of the connective tissue that is unable to metastasize but is associated with a high local recurrence rate. Nuclear b-catenin is the most commonly used histological marker of DF; however, clinical and biological predictive markers guiding the treatment and follow-up of DF are still lacking. Normally, b-catenin is regulated by the cytoplasmic multiprotein complex of adenomatous polyposis coli (APC), axin, casein kinase 1a (CK1a), and glycogen synthase kinase 3b (GSK-3b); this phosphorylates and degrades b-catenin, which would otherwise translocate to the nucleus. The aim of this study was to analyse the expression and localization of the b-catenin–protein complex of the Wnt pathway in cells isolated from DF patients. Methods and results: We isolated cells from biopsies of DF patients, and demonstrated, by immunofluorescence and immunoblot analyses, that it is almost exclusively nuclear GSK-3b that colocalizes and interacts with b-catenin. The nuclear translocation of b-catenin and GSK-3b is not correlated with CTNNB1 mutations. In DF samples, the multiprotein complex is disrupted, as the cytoplasmic localization of APC and axin makes interaction with the nuclear b-catenin and GSK-3b impossible. Conclusions: Our data suggest that GSK-3b is an additional DF marker with an important role in the aetiopathogenesis of this entity.

Nuclear GSK-3β segregation in desmoid-type fibromatosis.

Rastrelli M;SOMMARIVA, ANTONIO;ROSSI, CARLO RICCARDO;
2013

Abstract

Aims: Desmoid-type fibromatosis (DF) is a rare benign myofibroblastic neoplasm of the connective tissue that is unable to metastasize but is associated with a high local recurrence rate. Nuclear b-catenin is the most commonly used histological marker of DF; however, clinical and biological predictive markers guiding the treatment and follow-up of DF are still lacking. Normally, b-catenin is regulated by the cytoplasmic multiprotein complex of adenomatous polyposis coli (APC), axin, casein kinase 1a (CK1a), and glycogen synthase kinase 3b (GSK-3b); this phosphorylates and degrades b-catenin, which would otherwise translocate to the nucleus. The aim of this study was to analyse the expression and localization of the b-catenin–protein complex of the Wnt pathway in cells isolated from DF patients. Methods and results: We isolated cells from biopsies of DF patients, and demonstrated, by immunofluorescence and immunoblot analyses, that it is almost exclusively nuclear GSK-3b that colocalizes and interacts with b-catenin. The nuclear translocation of b-catenin and GSK-3b is not correlated with CTNNB1 mutations. In DF samples, the multiprotein complex is disrupted, as the cytoplasmic localization of APC and axin makes interaction with the nuclear b-catenin and GSK-3b impossible. Conclusions: Our data suggest that GSK-3b is an additional DF marker with an important role in the aetiopathogenesis of this entity.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11577/2635056
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact